Arxcel - Excellence in Prescription Benefit Management
Arxcel Home PageHealth CareServicesCEO FocusCase StudiesLinksContactExpert TopicsNewsletter
 

PRESS RELEASES

Corporate benefit executives identify ways to curb prescription drug prices
Annual Arxcel study reveals that corporate benefit executives blame high prescription costs on drug manufacturers

PBM consultancy wins three-year contract to evaluate
Pittsburgh business coalition’s prescription drug program
Arxcel to audit 8.4 million Rx claims for Pittsburgh Business Group on Health

Unique Pharmacy Benefit Analysis Gives Upper Hand to Local Health Plan
Arxcel works with State-Wide Schools Cooperative Health Plan to protect prescription benefits for 21,000 New Yorkers

NEWSLETTERS

• 1st Quarter 2008   PDF
     Pharmacogenomics benefits and barriers, Something to consider

• 4th Quarter 2007   PDF
     Pharmacogenomics promises better drug performance, FDA gains new powers

• 3rd Quarter 2007   PDF
     Prescription Drugs on TV shows, 2007 Survey Results, Client News Briefs

• 2nd Quarter 2007   PDF
     Legislating PBMs, Pharmacists seek collective bargaining, Arxcel previews survey

• 1st Quarter 2007   PDF
     CVS/Caremark Merger, Drug Pricing Changes

• 4th Quarter 2006
   Rising Health Care Costs, Voluntary PBM Standards, Robbins Leads

• 3rd Quarter 2006
   Introduction to ArxAnalysis, Oversight Trend, Capital Update

• 2nd Quarter 2006
   Arxcel survey results, Doctors surveyed on generic drugs, FDA Update

• 1st Quarter 2006
   Confusion over new Medicare program, New drugs to go generic, FDA Update

• 4th Quarter 2005
    Ways to Manage Depression, Medicare Beneficiaries Sustain Their Confusion about the Program, and FDA Update

• 3rd Quarter 2005
    Co-Pay Confusion, FDA Scrutiny, and FDA Update

• 2nd Quarter 2005
    2005 Arxcel Survey Monitors the Pulse of Prescription Benefit Programs Nationwide, Choosing the Right Rx, and FDA Update

• 1st Quarter 2005
    15% Drug Trend Anticipated, 2005 Survey Underway, and FDA Update

• 4th Quarter 2004
    PBM Audits, Drugs From Canada, and FDA Updates

• Fall 2003
    PBM Investigations, Generic Pricing Update, and FDA Updates

• Spring 2003
    The 2003 Arxcel Prescription Benefit Research Survey, Generic Pricing, and FDA Updates

• Winter 2003
    Prior Authorization, Upcoming 2003 Arxcel Prescription Benefit Research Survey, Prilosec

• Fall 2002
    Therapeutic Interchange and Step Therapy Programs

• Summer 2002
    Drug Research and Development, Drug Advertising and Prilosec

• Spring 2002
    Injectable Medications and the 2002 Arxcel Pharmaceutical Benefits Research Survey Results

• Winter 2002
    Arxcel Newsletter covers Generic Drugs - Drugs Coming Off Patent


Last updated:
© Arxcel, Inc.